Vir Biotechnology, Inc. Employee Count
The employee counts Vir Biotechnology, Inc. states in its annual reports on SEC EDGAR, each as filed.
- 2025-12-31: Employees (as filed) 367; Filing 2026-02-23; Lease expense per employee $50,275.20.
- 2024-12-31: Employees (as filed) 408; Filing 2025-02-27; Lease expense per employee $53,313.73.
- 2023-12-31: Employees (as filed) 587; Filing 2024-02-26; Lease expense per employee $42,470.19.
- 2022-12-31: Employees (as filed) 576; Filing 2023-02-28; Lease expense per employee $45,288.19.
- Available history
- 2019-12-31 to 2025-12-31
Historical Employee Count
| Date | Employees (as filed) | Filing | Lease expense per employee |
|---|---|---|---|
| 2025-12-31 | 367 | 2026-02-23 | $50,275.20 total lease cost |
| 2024-12-31 | 408 | 2025-02-27 | $53,313.73 total lease cost |
| 2023-12-31 | 587 full-time | 2024-02-26 | $42,470.19 total lease cost |
| 2022-12-31 | 576 full-time | 2023-02-28 | $45,288.19 total lease cost |
| 2021-12-31 | 444 full-time | 2022-02-28 | $37,022.52 total lease cost |
| 2020-12-31 | 327 full-time | 2021-02-25 | $22,474.01 total lease cost |
| 2019-12-31 | 229 full-time | 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |